Vaccinex, Inc. - Integrated biomarker trials of VX15/2503 (pepinemab) in combination with checkpoint inhibitors in window of opportunity studies in solid tumors

Sunday, March 31, 2019 1:00 p.m. ET  

Supporting Materials

Title
Vaccinex, Inc. - Integrated biomarker trials of VX15/2503 (pepinemab) in combination with checkpoint inhibitors in window of opportunity studies in solid tumors
Date / Time
03/31/19 1:00 p.m. ET